Topic Parkinson's Disease Discover the archives of Parkinson's disease and related articles Parkinson's Disease 29 Jun, 2022 Read Time: 3 mins Congress highlights Article New research on Lewy bodies, Pisa syndrome, and changes in the gut New research showing improved visualization of Lewy bodies, structural brain changes in Pisa... Mental Health 28 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 4 — June 28th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 27 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 3 — June 27th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 2 — June 26th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Migraine, Parkinson's Disease 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 1 — June 25th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Alzheimer's Disease, Parkinson's Disease 29 Oct, 2020 Read Time: 3 mins Congress highlights Gut bacteria may trigger Alzheimer’s disease The role of the gut and it’s microbiota in neurodegerenative diseases have gain a lot of attention... Mental Health 03 Oct, 2020 Read Time: 2 mins Congress highlights Brain health becomes a global priority For years, the massive burden of mortality and morbidity caused by neurological diseases was not... Alzheimer's Disease, Parkinson's Disease 16 Apr, 2020 Read Time: 2 mins Article COVID-19 and Dementia: a conjunction of pandemics The complexities of preventing and managing infection are multiplied in people living with dementia.... Mental Health 22 Mar, 2020 What role should patients play in treatment decision making? Mental Health 14 Feb, 2020 Read Time: 3 mins Article Real-world evidence — raising organizational fluency through interactive learning techniques Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and... Parkinson's Disease 17 Apr, 2019 Read Time: 4 mins Congress highlights Gait freezing - defrosted The assessment and therapeutic options for complex gait disorders has never been so promising. During... Parkinson's Disease 10 Apr, 2019 Read Time: 3 mins Congress highlights What the brain teaches us about α-synuclein In all affected brain regions, α-synuclein accumulates only in specific cell types, and only in... Parkinson's Disease 15 Feb, 2019 Read Time: 3 mins Article New therapeutic technologies and targets for Parkinson’s disease A gastroretentive capsule containing multiple layers of biodegradable film, intraoral infusion via a... Mental Health 14 Jan, 2019 Read Time: 3 mins Congress highlights Mutual benefits: Public–Private Partnerships in CNS Research Public–Private Partnerships are being developed worldwide to facilitate collaboration between... Alzheimer's Disease, Parkinson's Disease 14 Jan, 2019 Read Time: 3 mins Congress highlights Gut bacteria may trigger Alzheimer’s disease The role of the gut and it’s microbiota in neurodegerenative diseases have gain a lot of attention... Mental Health 09 May, 2018 Read Time: 3 mins Congress highlights Investing in recovery – translating intervention into action You would think that the behaviour of a flock of starlings would have little to do with mental health... Parkinson's Disease 09 May, 2018 Read Time: 4 mins Congress highlights Advances in Parkinson’s disease research: one step closer to identify subjects in the prodromal stage, predicting conversion and potential for disease-modifying therapy The incidence of Parkinson’s disease (PD) is increasing. The reasons are unknown. Identifying people... Parkinson's Disease 23 Mar, 2018 Read Time: 4 mins Congress highlights Advances in Parkinson’s disease research: one step closer to identify subjects in the prodromal stage, predicting conversion and potential for disease-modifying therapy The incidence of Parkinson’s disease (PD) is increasing. The reasons are unknown. Identifying people... Mental Health 05 Mar, 2018 Read Time: 3 mins Congress highlights Networking - a brilliant take off or a flight of fancy? You would think that the behaviour of a flock of starlings would have little to do with mental health... Mental Health 20 Sep, 2017 Read Time: 2 mins Article Value of Treatment: European Brain Council publishes landmark report Greater clinical benefit for patients and gains in cost-effectiveness for society -- both can be... Parkinson's Disease 12 Apr, 2017 Read Time: 4 mins Congress highlights Boom or bust in biomarkers: is the heterogeneity of PD slowing our search? We should combine forces, harmonise protocols for collecting material, and accept the need to combine... Parkinson's Disease 12 Apr, 2017 Read Time: 4 mins Congress highlights Mutations matter in the intricate dance of determinants Mutations in several genes contribute in differing degrees to the causation of PD. But the gene... Parkinson's Disease 12 Apr, 2017 Read Time: 5 mins Congress highlights From bowels to brain: the prion hypothesis in Parkinson’s The idea that Parkinson’s Disease begins with alpha-synuclein pathology in the gut which then spreads... Parkinson's Disease 12 Apr, 2017 Read Time: 4 mins Congress highlights Pathways to cell death Both mitochondrial and lysosomal function decrease with age, which is the major risk factor for PD,... Parkinson's Disease 12 Apr, 2017 Read Time: 4 mins Congress highlights Plea for personalised medicine in PD Well-established therapies for Parkinson’s Disease focus on motor symptoms. In comparison, the... Alzheimer's Disease, Parkinson's Disease 30 Mar, 2017 Read Time: 5 mins Article Big Data - Big Opportunities Scientists are working to harness the power of “big data” compiled from internet-connected devices.... Alzheimer's Disease, Parkinson's Disease 22 Jun, 2016 Read Time: 3 mins Congress highlights Highlights from the neurodegenerative disease sessions Primary progressive aphasia, amyloid PET in Alzheimer’s diagnosis, treating Parkinson’s tremor, and... Parkinson's Disease 15 Jun, 2016 Read Time: 2 mins Congress highlights Neglected problems of speech and swallowing respond to integrated management Speech problems can appear before classical Parkinsonian symptoms and are a sensitive marker of... Parkinson's Disease 15 Jun, 2016 Read Time: 3 mins Congress highlights Biomarkers chart path from prodrome to Parkinson’s Disease Reliable biomarkers of high risk would open up the prospect of preventing Parkinson’s Disease during... Parkinson's Disease 09 Jun, 2016 Read Time: 4 mins Congress highlights Quality of life, quality of care: shared perspectives in Parkinson’s Disease For both practical and ethical reasons, managing chronic conditions such as Parkinson’s Disease... Parkinson's Disease 09 Jun, 2016 Read Time: 4 mins Congress highlights Non-motor symptoms in Parkinson’s Disease: burden and role in possible prodrome Parkinson’s Disease is not just a disease of the brain, it is not just a disease of dopamine, and –... Most Popular
